Coronavirus channel feed

Covid-19 roundup: As­traZeneca paus­es vac­cine tri­al for chil­dren as blood clot probe con­tin­ues; EMA to in­ves­ti­gate whether Sput­nik V tri­als met GCP stan­dards — re­port

5 years ago

Icosavax keeps up the ex­cite­ment for its VLP 'soc­cer balls,' earn­ing the RA Cap­i­tal stamp of ap­proval in $100M Se­ries B

5 years ago
Financing

Can em­ploy­ers man­date Covid-19 vac­cines un­der emer­gency au­tho­riza­tions? It’s com­pli­cat­ed

5 years ago
FDA+

Covid-19 roundup: EMA of­fi­cial says 'clear' link be­tween As­traZeneca shot and blood clots — re­port; No­vavax al­lows place­bo group to get vac­cine

5 years ago

Covid-19 roundup: FDA up­dates Mod­er­na vac­cine dose per vial counts; Vir's an­ti­body shows promise against vari­ants

5 years ago

FDA un­veils top 5 pri­or­i­ties for re­work­ing its Covid-19 re­sponse mov­ing for­ward

5 years ago
FDA+

Take­da, CSL Behring fold big plas­ma al­liance af­ter PhI­II flop — join­ing a slew of an­ti­bod­ies that failed to help hos­pi­tal­ized pa­tients

5 years ago
R&D

Af­ter mil­lions of Covid vac­cine dos­es were botched, the feds hand con­trol of a trou­bled Emer­gent Bio fa­cil­i­ty to J&J

5 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Catal­ent gets the FDA's go-ahead on J&J shot; As­traZeneca taps a new con­trac­tor

5 years ago
Manufacturing

Covid-19 roundup: Emer­gen­t's er­ror costs J&J a vac­cine batch; Pfiz­er head says EU re­stric­tions slow vac­cine dis­tri­b­u­tion process

5 years ago
Manufacturing

US gov­ern­ment does not own any remde­sivir patents, GAO re­port finds

5 years ago
R&D

Rare blood clot events more com­mon among women re­ceiv­ing As­traZeneca Covid-19 vac­cine, EMA says

5 years ago

Covid-19 roundup: As­traZeneca vac­cine halt­ed in Ger­many for be­low-60 pop­u­la­tion; Pfiz­er says Covid-19 vac­cine has 100% ef­fi­ca­cy in chil­dren ages 12-15

5 years ago

BioN­Tech makes a splash with $10B+ pro­jec­tion for 2021 Covid-19 vac­cine sales

5 years ago

Covid-19 roundup: CDC study con­firms re­al-world ef­fi­ca­cy of mR­NA shots; In­dia ex­port lim­its de­lay CO­V­AX ship­ments

5 years ago

Glax­o­SmithK­line of­fers fill-fin­ish ca­pac­i­ty to No­vavax for UK sup­ply of Covid-19 vac­cine

5 years ago
Deals
Manufacturing

FDA can do more to en­sure di­ver­si­ty in clin­i­cal tri­als, ex­perts say — in­clud­ing some con­struc­tive bad­ger­ing

5 years ago
FDA+

Eli Lil­ly, Glax­o­SmithK­line-Vir re­lease pos­i­tive but dif­fi­cult-to-in­ter­pret com­bo an­ti­body da­ta

5 years ago
R&D

Hu­mani­gen de­clares win in se­vere Covid-19, de­liv­er­ing much-need­ed pan­dem­ic weapon and vault­ing ahead on post-Shkre­li turn­around

5 years ago
R&D

Covid-19 roundup: Mod­er­na pass­es 100M mark for US vac­cines in land­mark mo­ment; Fake Pfiz­er vac­cine found in Mex­i­co

5 years ago
R&D

Glax­o­SmithK­line and Vir sub­mit Covid-19 mAb for emer­gency au­tho­riza­tion

5 years ago
FDA+

EMA: On­go­ing study da­ta of Cell­tri­on’s mAb enough to al­low its use in some Covid-19 pa­tients

5 years ago
FDA+

Covid-19 roundup: Cuo­mo ad­min­is­tra­tion al­leged­ly gave Re­gen­eron's George Yan­copou­los spe­cial pref­er­ence for test­ing — re­port; Act­ing tough, EU calls on As­traZeneca to 'catch up' on vac­cine de­liv­ery be­fore ex­port­ing

5 years ago

US to no longer dis­trib­ute Eli Lil­ly’s bam­lanivimab alone due to coro­n­avirus vari­ants

5 years ago
Pharma
FDA+
First page Previous page 30313233343536 Next page Last page
A service from the Financial Times